Cost of pelvic organ prolapse surgery in the United States

Leslee L. Subak, L Elaine Waetjen, Stephen Van Den Eeden, David H. Thom, Eric Vittinghoff, Jeanette S. Brown

Research output: Contribution to journalArticle

363 Citations (Scopus)

Abstract

OBJECTIVE: To estimate the annual direct cost to society of pelvic organ prolapse operations in the United States. METHODS: We multiplied the number of pelvic organ prolapse operations identified in the 1997 National Hospital Discharge Survey by national average Medicare reimbursement for physician services and hospitalizations. Although this reimbursement does not estimate the actual cost, it is a proxy for cost, which estimates what society pays for the procedures. RESULTS: In 1997, direct costs of pelvic organ prolapse surgery were $1012 million (95% confidence interval [CI] $775, 1251 million), including $494 million (49%) for vaginal hysterectomy, $279 million (28%) for cystocele and rectocele repair, and $135 million (13%) for abdominal hysterectomy. Physician services accounted for 29% ($298 million) of total costs, and hospitalization accounted for 71% ($714 million). Twenty-one percent of pelvic organ prolapse operations included urinary incontinence procedures ($218 million). If all operations were reimbursed by non-Medicare sources, the annual estimated cost would increase by 52% to $1543 million. CONCLUSION: The annual direct costs of operations for pelvic organ prolapse are substantial.

Original languageEnglish (US)
Pages (from-to)646-651
Number of pages6
JournalObstetrics and Gynecology
Volume98
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Pelvic Organ Prolapse
Costs and Cost Analysis
Hospitalization
Rectocele
Cystocele
Health Care Surveys
Physicians
Vaginal Hysterectomy
Urinary Incontinence
Proxy
Medicare
Hysterectomy
Confidence Intervals

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Subak, L. L., Waetjen, L. E., Van Den Eeden, S., Thom, D. H., Vittinghoff, E., & Brown, J. S. (2001). Cost of pelvic organ prolapse surgery in the United States. Obstetrics and Gynecology, 98(4), 646-651. https://doi.org/10.1016/S0029-7844(01)01472-7

Cost of pelvic organ prolapse surgery in the United States. / Subak, Leslee L.; Waetjen, L Elaine; Van Den Eeden, Stephen; Thom, David H.; Vittinghoff, Eric; Brown, Jeanette S.

In: Obstetrics and Gynecology, Vol. 98, No. 4, 2001, p. 646-651.

Research output: Contribution to journalArticle

Subak, LL, Waetjen, LE, Van Den Eeden, S, Thom, DH, Vittinghoff, E & Brown, JS 2001, 'Cost of pelvic organ prolapse surgery in the United States', Obstetrics and Gynecology, vol. 98, no. 4, pp. 646-651. https://doi.org/10.1016/S0029-7844(01)01472-7
Subak, Leslee L. ; Waetjen, L Elaine ; Van Den Eeden, Stephen ; Thom, David H. ; Vittinghoff, Eric ; Brown, Jeanette S. / Cost of pelvic organ prolapse surgery in the United States. In: Obstetrics and Gynecology. 2001 ; Vol. 98, No. 4. pp. 646-651.
@article{d7db4a743f2a4d62a1f042d0cf04f185,
title = "Cost of pelvic organ prolapse surgery in the United States",
abstract = "OBJECTIVE: To estimate the annual direct cost to society of pelvic organ prolapse operations in the United States. METHODS: We multiplied the number of pelvic organ prolapse operations identified in the 1997 National Hospital Discharge Survey by national average Medicare reimbursement for physician services and hospitalizations. Although this reimbursement does not estimate the actual cost, it is a proxy for cost, which estimates what society pays for the procedures. RESULTS: In 1997, direct costs of pelvic organ prolapse surgery were $1012 million (95{\%} confidence interval [CI] $775, 1251 million), including $494 million (49{\%}) for vaginal hysterectomy, $279 million (28{\%}) for cystocele and rectocele repair, and $135 million (13{\%}) for abdominal hysterectomy. Physician services accounted for 29{\%} ($298 million) of total costs, and hospitalization accounted for 71{\%} ($714 million). Twenty-one percent of pelvic organ prolapse operations included urinary incontinence procedures ($218 million). If all operations were reimbursed by non-Medicare sources, the annual estimated cost would increase by 52{\%} to $1543 million. CONCLUSION: The annual direct costs of operations for pelvic organ prolapse are substantial.",
author = "Subak, {Leslee L.} and Waetjen, {L Elaine} and {Van Den Eeden}, Stephen and Thom, {David H.} and Eric Vittinghoff and Brown, {Jeanette S.}",
year = "2001",
doi = "10.1016/S0029-7844(01)01472-7",
language = "English (US)",
volume = "98",
pages = "646--651",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cost of pelvic organ prolapse surgery in the United States

AU - Subak, Leslee L.

AU - Waetjen, L Elaine

AU - Van Den Eeden, Stephen

AU - Thom, David H.

AU - Vittinghoff, Eric

AU - Brown, Jeanette S.

PY - 2001

Y1 - 2001

N2 - OBJECTIVE: To estimate the annual direct cost to society of pelvic organ prolapse operations in the United States. METHODS: We multiplied the number of pelvic organ prolapse operations identified in the 1997 National Hospital Discharge Survey by national average Medicare reimbursement for physician services and hospitalizations. Although this reimbursement does not estimate the actual cost, it is a proxy for cost, which estimates what society pays for the procedures. RESULTS: In 1997, direct costs of pelvic organ prolapse surgery were $1012 million (95% confidence interval [CI] $775, 1251 million), including $494 million (49%) for vaginal hysterectomy, $279 million (28%) for cystocele and rectocele repair, and $135 million (13%) for abdominal hysterectomy. Physician services accounted for 29% ($298 million) of total costs, and hospitalization accounted for 71% ($714 million). Twenty-one percent of pelvic organ prolapse operations included urinary incontinence procedures ($218 million). If all operations were reimbursed by non-Medicare sources, the annual estimated cost would increase by 52% to $1543 million. CONCLUSION: The annual direct costs of operations for pelvic organ prolapse are substantial.

AB - OBJECTIVE: To estimate the annual direct cost to society of pelvic organ prolapse operations in the United States. METHODS: We multiplied the number of pelvic organ prolapse operations identified in the 1997 National Hospital Discharge Survey by national average Medicare reimbursement for physician services and hospitalizations. Although this reimbursement does not estimate the actual cost, it is a proxy for cost, which estimates what society pays for the procedures. RESULTS: In 1997, direct costs of pelvic organ prolapse surgery were $1012 million (95% confidence interval [CI] $775, 1251 million), including $494 million (49%) for vaginal hysterectomy, $279 million (28%) for cystocele and rectocele repair, and $135 million (13%) for abdominal hysterectomy. Physician services accounted for 29% ($298 million) of total costs, and hospitalization accounted for 71% ($714 million). Twenty-one percent of pelvic organ prolapse operations included urinary incontinence procedures ($218 million). If all operations were reimbursed by non-Medicare sources, the annual estimated cost would increase by 52% to $1543 million. CONCLUSION: The annual direct costs of operations for pelvic organ prolapse are substantial.

UR - http://www.scopus.com/inward/record.url?scp=0034806983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034806983&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(01)01472-7

DO - 10.1016/S0029-7844(01)01472-7

M3 - Article

C2 - 11576582

AN - SCOPUS:0034806983

VL - 98

SP - 646

EP - 651

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -